H

Huakang Biomedical Holdings Co Ltd
HKEX:8622

Watchlist Manager
Huakang Biomedical Holdings Co Ltd
HKEX:8622
Watchlist
Price: 0.184 HKD -0.54% Market Closed
Market Cap: 92.1m HKD
Have any thoughts about
Huakang Biomedical Holdings Co Ltd?
Write Note

Huakang Biomedical Holdings Co Ltd
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Huakang Biomedical Holdings Co Ltd
Accounts Receivables Peer Comparison

Comparables:
K
876
K
1134
1120
O
6929

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
H
Huakang Biomedical Holdings Co Ltd
HKEX:8622
Accounts Receivables
ÂĄ9.3m
CAGR 3-Years
-1%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
K
Kaisa Health Group Holdings Ltd
HKEX:876
Accounts Receivables
HK$179.2m
CAGR 3-Years
37%
CAGR 5-Years
15%
CAGR 10-Years
9%
K
Kelfred Holdings Ltd
HKEX:1134
Accounts Receivables
HK$109.1m
CAGR 3-Years
5%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Arts Optical International Holdings Ltd
HKEX:1120
Accounts Receivables
HK$394.2m
CAGR 3-Years
8%
CAGR 5-Years
9%
CAGR 10-Years
-1%
O
OrbusNeich Medical Group Holdings Ltd
HKEX:6929
Accounts Receivables
$38m
CAGR 3-Years
13%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Huakang Biomedical Holdings Co Ltd's Accounts Receivables?
Accounts Receivables
9.3m CNY

Based on the financial report for Dec 31, 2023, Huakang Biomedical Holdings Co Ltd's Accounts Receivables amounts to 9.3m CNY.

What is Huakang Biomedical Holdings Co Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
-3%

Over the last year, the Accounts Receivables growth was -1%. The average annual Accounts Receivables growth rates for Huakang Biomedical Holdings Co Ltd have been -1% over the past three years , -3% over the past five years .

Back to Top